Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
130
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Septerna Inc. market cap is $1.9B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Septerna Inc. 52 week high is $53.34 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Septerna Inc. 52 week low is $21.63 as of November 18, 2026.
Septerna Inc. stock price today is $39.61.
Septerna Inc. stock price yesterday was $40.02.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Septerna Inc.'s P/E ratio is -31.02.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Septerna Inc. P/B ratio is 4.4339.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Septerna Inc. 50-day moving average is $40.62.